| Financial Year |
March 31 2023 |
| Monetary Funds |
336,356,715.09 |
| Held-for-trading Financial Assets |
3,000,000.00 |
| Notes Receivable |
2,194,390.50 |
| Accounts Receivable |
159,819,619.62 |
| Advances to Suppliers |
30,971,128.59 |
| Other Receivables |
8,444,933.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
95,390,238.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
101,847.43 |
| Total Current Assets |
639,634,253.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
36,893,210.07 |
| Investment Properties |
1,318,899.52 |
| Fixed Assetes |
688,371,550.59 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
91,063,696.99 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
71,599,937.84 |
| Other Non-Current Assets |
78,414,038.60 |
| Sub-Total of Non-Current Assets |
987,301,333.61 |
| Total Assets |
1,626,935,586.99 |
| Short-Term Loans |
19,210,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
310,804,888.77 |
| Accounts Payable |
140,306,835.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,315,766.62 |
| Taxes Payable |
214,975.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
46,636,923.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,851,112.83 |
| Sub-Total of Current Liabilities |
552,437,698.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
503,307.00 |
| Other Non-Current Liabilities |
157,248.84 |
| Sub-Total of Non-Current Liabilities |
1,092,212.43 |
| Total Liabilities |
553,529,910.80 |
| Paid-In Capital(Or Share Stock) |
131,447,829.00 |
| Capital Surplus |
410,149,610.29 |
| Surplus Reserve |
118,574,488.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
424,156,590.88 |
| Minority Stockholder's Interest |
-10,922,842.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,084,328,518.43 |
| Owner's Equity（Stockholder's Equity） |
1,073,405,676.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,626,935,586.99 |
